mRNA malaria vaccine

Learn more about how the mRNA and lipid nanoparticles team is developing an mRNA vaccine to overcome the limitations of traditional malaria vaccines.

The problem

Despite decades of research, traditional malaria vaccines have limitations, including poor efficacy and interference from previous infection.

The solution

We developed an mRNA vaccine incorporating a potent vaccine adjuvant which enables the generation of liver-resident memory T cells to prevent malaria.

The impact

Our mRNA vaccine shows promise for effective protection against malaria, particularly in malaria-endemic regions, as it is not impaired by previous exposure to blood-stage infection, unlike traditional vaccines.

Research team